CIK 0001130166
- Non-accelerated filer
- Smaller reporting company
Bio Green Med Solution, Inc.
Sign in to watch- Tickers
- BGMS BGMSP
- Exchange
- Nasdaq, OTC
- Industry
- Wholesale-Durable Goods, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 911766850
- Phone
- +1 908-517-7330
- Business address
- 200 CONNELL DRIVE, SUITE 1500, BERKELEY HEIGHTS, NJ, 07922
- Former names
- Cyclacel Pharmaceuticals, Inc., XCYTE THERAPIES INC
Securities
- BGMS Common Stock Nasdaq
- BGMSP Common stock OTC
- 4 Open-market buy 10% owner bought 23,900 shares at $2.09 ($49,951)
- 4 Open-market buy E.V.P., Finance & C.O.O. bought 1,950 shares at $2.25 ($4,388)
- 4 Open-market buy President & C.E.O. bought 12,500 shares at an average $2.32 ($28,990)
- 4 Open-market buy President & C.E.O. bought 15,000 shares at an average $2.59 ($38,780)
- 4 Open-market sale 10% owner sold 1,600 shares at $2.84 ($4,544)
- 4 Open-market sale 10% owner sold 66,700 shares at an average $2.94 ($195,978)
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale 10% owner sold 38,900 shares at $3.09 ($120,201)
- 4 Open-market buy President & C.E.O. bought 5,800 shares at $2.75 ($15,950)
- 4 Open-market buy Senior VP, Research bought 3,000 shares at $2.90 ($8,700)
- 4 Open-market buy VP, Business Development bought 5,000 shares at an average $2.89 ($14,444)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 195,700 shares at an average $4.07 ($797,259)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 15 of 26 · 511 filings